|

- 积分
- 0
- 威望
- 0
- 包包
- 834
|
1. A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection. Umeda Y, Matsuda H, Sadamori H, Matsukawa H, Yagi T, Fujiwara T. World J Surg. 2011 Jan;35(1):170-7.
8 ?5 y3 p' f( g/ _4 n( m% KPMID:20922387[PubMed - indexed for MEDLINE]
9 F0 |5 `" P* s2. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Lu MD, Yin XY, Xie XY, Xu HX, Xu ZF, Liu GJ, Kuang M, Zheng YL. Br J Surg. 2005 Nov;92(11):1393-8.0 r* L3 T6 c* \1 H
PMID:16044409[PubMed - indexed for MEDLINE]
# X- {& ~, k' Z3. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. Matsuda M, Fujii H, Kono H, Matsumoto Y. J Hepatobiliary Pancreat Surg. 2001;8(4):353-9.
: t% [- Q* M9 b% K3 KPMID:11521181[PubMed - indexed for MEDLINE]' B2 l! t: s# M) q1 N5 L4 r
|
|